# A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers

> **NCT01612806** · NA · TERMINATED · sponsor: **Integra LifeSciences Corporation** · enrollment: 31 (actual)

## Conditions studied

- Venous Stasis Ulcer

## Interventions

- **DEVICE:** PriMatrix
- **DEVICE:** PriMatrix Ag
- **PROCEDURE:** moist wound therapy

## Key facts

- **NCT ID:** NCT01612806
- **Lead sponsor:** Integra LifeSciences Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Site selection
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612806, "A Multi-center, Prospective, Randomized Study With PriMatrix and PriMatrix Ag for the Treatment of Venous Leg Ulcers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01612806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*